Related Experiment Video
Updated: Jun 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design
Colin M Tice1, Wei Zhao, Zhenrong Xu
1Vitae Pharmaceuticals, 502 West Office Center Drive, Fort Washington, PA 19034, USA.
Abstract:
Structure-guided drug design led to the identification of a class of spirocyclic ureas which potently inhibit human 11beta-HSD1 in vitro. Lead compound 10j was shown to be orally bioavailable in three species, distributed into adipose tissue in the mouse, and its (R) isomer 10j2 was efficacious in a primate pharmacodynamic model.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Sulfonylureas
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Intrauterine Drug Delivery Systems
Antihypertensive Drugs: Thiazide-Class Diuretics
Urea Cycle
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

